智通财经APP讯,歌礼制药-B(01672)公布,公司于2026年11月4日向42名参与者授出购股权以认购合共180万股公司每股面值0.0001美元的普通股,所授出购股权的行使价为每股股份4.923港元,有效期10年。
智通财经APP讯,歌礼制药-B(01672)公布,公司于2026年11月4日向42名参与者授出购股权以认购合共180万股公司每股面值0.0001美元的普通股,所授出购股权的行使价为每股股份4.923港元,有效期10年。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.